NEW YORK (GenomeWeb) – Invitae reported on Tuesday after the close of the market a nearly 10-fold year-over-year increase in its revenues for the fourth quarter. 

The San Francisco-based cancer genetics testing firm said that it recorded $875,000 in revenues for the three months ended Dec. 31, 2014, compared to $88,000 in the year-ago quarter. More than 1,800 billable reports were delivered during the recently completed quarter, Invitae, which went public last month, said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.